Metraipolis › archive › dc_217acd35ef52

A Comparative Analysis of the Efficacy, Safety and Mechanism of Action of Flebogamma DIF, Fostamatinib and Romiplostim in Immune Thrombocytopenia — Europe PMC PMID:41900959

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41900959
DOI
10.3390/life16030440
License (as archived)
solo-consultazione
Archived
2026-11-04T23:43:32.637Z
SHA-256 of the archived text
f6bb0592879769379cf19cb3b92cf2a6537d2ce97bca71e735fd6b02e10debbc
Stable URL of this page
https://metraipolis.com/documento/dc_217acd35ef52

How to cite

A Comparative Analysis of the Efficacy, Safety and Mechanism of Action of Flebogamma DIF, Fostamatinib and Romiplostim in Immune Thrombocytopenia — Europe PMC PMID:41900959 — Europe PMC (en), https://europepmc.org/article/MED/41900959 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_217acd35ef52 (Metraipolis archive dc_217acd35ef52, sha256 f6bb0592879769379cf19cb3b92cf2a6537d2ce97bca71e735fd6b02e10debbc)
BibTeX
@misc{dc217acd35ef52,
  title = {A Comparative Analysis of the Efficacy, Safety and Mechanism of Action of Flebogamma DIF, Fostamatinib and Romiplostim in Immune Thrombocytopenia — Europe PMC PMID:41900959},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41900959},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_217acd35ef52; sha256 f6bb0592879769379cf19cb3b92cf2a6537d2ce97bca71e735fd6b02e10debbc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41900959. Agents can read the archived copy with the MCP tool read_document.